Christine Silverstein

Christine Silverstein serves as the Chief Financial Officer at Artios, a company focused on combating cancer through innovative DNA damage response strategies, since February 2024. Silverstein's extensive experience includes board membership at Abeona Therapeutics and Marinus Pharmaceuticals, where roles involve strategic oversight in organizations dedicated to gene therapies and seizure disorder treatments. Previous positions include CFO roles at Excision BioTherapeutics and Emendo Biotherapeutics, along with senior financial leadership at Relmada Therapeutics and PlasmaTech BioPharmaceuticals. Silverstein has a strong educational background, with certifications from Harvard Division of Continuing Education, complemented by studies at St. John's University and the New York Institute of Finance.